Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Prostaglandins Other Lipid Mediat ; 155: 106564, 2021 08.
Artículo en Inglés | MEDLINE | ID: mdl-34004336

RESUMEN

The aim of this study was to investigate the in vivo and in vitro effects of dietary ω-6 and ω-3 polyunsaturated fatty acids (PUFAs) and their derivatives on the expression of TP53 and their relationship with cellular proliferation and death in a murine mammary adenocarcinoma model. BALB/c mice were divided in three diet groups: chia oil (ChO) rich in ω-3, corn oil (CO) rich in ω-6/ω-3 and safflower oil (SO) rich in ω-6 and subcutaneously inoculated with LMM3 mammary tumor cell line. Results demonstrated that diets with higher concentration of omega-6 PUFAs induced an increment of linoleic and arachidonic acid on tumor cell membranes increasing ROS liberation, 12(S)-HHT generation, TP53, Ki67 expression and cell proliferation. However, diets enriched with high content in omega-3 PUFAs induced higher tumor cell apoptosis and tumor infiltration of CD3+ lymphocytes, lowest cell viability and proliferation. Dietary omega-3 PUFAs nutritional intervention can be used as a potential preventative strategy to inhibit the molecular signaling pathways involved in the mammary tumor growth process as the TP53.


Asunto(s)
Especies Reactivas de Oxígeno
2.
Semergen ; 47(1): 4-11, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33277178

RESUMEN

INTRODUCTION: Leukotriene receptor antagonists (LTRAs) are used as a therapeutic alternative in asthmatic patients. Different animal studies indicate that LTRAs can decrease intimal hyperplasia after vascular injury, and have a protective role in cerebral ischemia. OBJECTIVE: The aim of this study was to assess the role of leukotriene receptor antagonists in preventing the cardiovascular and ischemic stroke in humans. MATERIAL AND METHOD: A matched case-control study with a follow up period of three years has been conducted, investigating the effect of the LTRAs in the myocardial infarct (MI) risk, and in the ischemic stroke (IS) risk in asthmatic patients from San Cecilio University Hospital of Granada, and from two Primary Health Care Centers of Granada. RESULTS: 59 cases with MI and 108 cases with IS were included in the study, each of them with an equal number of controls matched by age and sex in each of the two Health Care Centers. Unlike for MI risk, the treatment with LTRAs was associated with a slight trend in reducing the risk of stroke, in both of the primary care controls (Odds ratios: 0.74 (0.37-1.47); 0.82 (0.4-1.67), for the first, and the second Health Centers Controls, respectively), but without reaching a statistical significance. CONCLUSIONS: The results did not confirm a protective effect of LTRAs on cardiovascular risk as suggested by different animal studies.


Asunto(s)
Trastornos Cerebrovasculares , Asma , Estudios de Casos y Controles , Humanos , Antagonistas de Leucotrieno
3.
Artículo en Inglés | MEDLINE | ID: mdl-22690714

RESUMEN

Urinary tract tumors are tenth in frequency, and many environmental carcinogens are excreted by urine. Interplay between chronic inflammatory urolithiasis and urothelial carcinogenesis is not well understood. Experimental evidences show that dietary melamine induce these events even at low concentrations. This is important because thousands of children were exposed to melamine through intentionally contaminated milk formula worldwide. We propose that an increased risk for urinary tumors in adult life may occur and screenings for early urinary signs may be necessary. Therefore, urothelial biology, melamine carcinogenic potential, and related epidemiology are discussed, recommending a preventive dietary polyunsaturated fatty acid-based supplementation, since they modulate such interplay in rodents.


Asunto(s)
Ácidos Grasos Insaturados/uso terapéutico , Contaminación de Alimentos , Fórmulas Infantiles/química , Triazinas/toxicidad , Urolitiasis/inducido químicamente , Neoplasias Urológicas/inducido químicamente , Neoplasias Urológicas/dietoterapia , Adulto , Animales , Pruebas de Carcinogenicidad , Carcinógenos/toxicidad , Bovinos , Causalidad , Comorbilidad , Suplementos Dietéticos , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Ratas , Medición de Riesgo , Triazinas/análisis , Urolitiasis/dietoterapia , Urolitiasis/epidemiología , Neoplasias Urológicas/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA